Literature DB >> 34330324

TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation.

Chuanle Wang1, Zhou Songyang1,2,3,4, Yan Huang5.   

Abstract

BACKGROUND: About 10-15% of tumor cells extend telomeres through the alternative lengthening of telomeres (ALT) mechanism, which is a recombination-dependent replication pathway. It is generally believed that ALT cells are related to the chromatin modification of telomeres. However, the mechanism of ALT needs to be further explored.
RESULTS: Here we found that TRIM28/KAP1 is preferentially located on the telomeres of ALT cells and interacts with telomeric shelterin/telosome complex. Knocking down TRIM28 in ALT cells delayed cell growth, decreased the level of C-circle which is one kind of extrachromosomal circular telomeric DNA, increased the frequency of ALT-associated promyelocytic leukemia bodies (APBs), led to telomere prolongation and increased the telomere sister chromatid exchange in ALT cells. Mechanistically, TRIM28 protects telomere histone methyltransferase SETDB1 from degradation, thus maintaining the H3K9me3 heterochromatin state of telomere DNA.
CONCLUSIONS: Our work provides a model that TRIM28 inhibits alternative lengthening of telomere phenotypes by protecting SETDB1 from degradation. In general, our results reveal the mechanism of telomere heterochromatin maintenance and its effect on ALT, and TRIM28 may serve as a target for the treatment of ALT tumor cells.
© 2021. The Author(s).

Entities:  

Keywords:  Alternative lengthening of telomere phenotypes; Heterochromatin; SETDB1; TRIM28/KAP1

Year:  2021        PMID: 34330324     DOI: 10.1186/s13578-021-00660-y

Source DB:  PubMed          Journal:  Cell Biosci        ISSN: 2045-3701            Impact factor:   7.133


  54 in total

1.  Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins.

Authors:  Dan Liu; Matthew S O'Connor; Jun Qin; Zhou Songyang
Journal:  J Biol Chem       Date:  2004-09-20       Impact factor: 5.157

Review 2.  Telomeres: no end in sight.

Authors:  E H Blackburn
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

Review 3.  Telomere length, stem cells and aging.

Authors:  Maria A Blasco
Journal:  Nat Chem Biol       Date:  2007-10       Impact factor: 15.040

4.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

Review 5.  The telomere syndromes.

Authors:  Mary Armanios; Elizabeth H Blackburn
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

6.  Telomere dysfunction and the initiation of genome instability.

Authors:  David M Feldser; Jennifer A Hackett; Carol W Greider
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

7.  Adult-onset pulmonary fibrosis caused by mutations in telomerase.

Authors:  Kalliopi D Tsakiri; Jennifer T Cronkhite; Phillip J Kuan; Chao Xing; Ganesh Raghu; Jonathan C Weissler; Randall L Rosenblatt; Jerry W Shay; Christine Kim Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-25       Impact factor: 11.205

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

Review 9.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

Review 10.  Telomere-driven diseases and telomere-targeting therapies.

Authors:  Paula Martínez; Maria A Blasco
Journal:  J Cell Biol       Date:  2017-03-02       Impact factor: 10.539

View more
  2 in total

Review 1.  Alternative Lengthening of Telomeres and Mediated Telomere Synthesis.

Authors:  Kailong Hou; Yuyang Yu; Duda Li; Yanduo Zhang; Ke Zhang; Jinkai Tong; Kunxian Yang; Shuting Jia
Journal:  Cancers (Basel)       Date:  2022-04-27       Impact factor: 6.575

2.  Identification of Key Proteins from the Alternative Lengthening of Telomeres-Associated Promyelocytic Leukemia Nuclear Bodies Pathway.

Authors:  Isaac Armendáriz-Castillo; Katherine Hidalgo-Fernández; Andy Pérez-Villa; Jennyfer M García-Cárdenas; Andrés López-Cortés; Santiago Guerrero
Journal:  Biology (Basel)       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.